ERP29 Antikörper (AA 151-179)
-
- Target Alle ERP29 Antikörper anzeigen
- ERP29 (Endoplasmic Reticulum Protein 29 (ERP29))
-
Bindungsspezifität
- AA 151-179
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ERP29 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
- Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogen
- This ERP29 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 151-179 amino acids from the Central region of human ERP29.
- Klon
- RB20540
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ERP29 Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- Haltbarkeit
- 6 months
-
-
Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas." in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, Vol. 18, Issue 4, pp. 352-9, (2016) (PubMed).
: "
-
Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas." in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, Vol. 18, Issue 4, pp. 352-9, (2016) (PubMed).
-
- Target
- ERP29 (Endoplasmic Reticulum Protein 29 (ERP29))
- Andere Bezeichnung
- ERP29 (ERP29 Produkte)
- Synonyme
- C12orf8 antikoerper, ERp28 antikoerper, ERp31 antikoerper, PDI-DB antikoerper, PDIA9 antikoerper, 1200015M03Rik antikoerper, 2810446M09Rik antikoerper, AW209030 antikoerper, Erp28 antikoerper, Erp31 antikoerper, PDI-Db antikoerper, endoplasmic reticulum protein 29 antikoerper, ERP29 antikoerper, Erp29 antikoerper
- Hintergrund
- ERP29 shows sequence similarity to the protein disulfide isomerase family. However, it lacks the thioredoxin motif characteristic of this family, suggesting that this protein does not function as a disulfide isomerase. The protein dimerizes and is thought to play a role in the processing of secretory proteins within the ER.
- Gen-ID
- 10961
- NCBI Accession
- NP_001029197, NP_006808
- UniProt
- P30040
-